First Business Financial Services is a bank holding company. Through its subsidiary, First Business Bank (the Bank), the company operates as a business bank, delivering a line of commercial banking products and services for small and medium-sized businesses, business owners, executives, personnel, and individuals. The company's products and services include those for business banking, private wealth, and bank consulting. Within business banking, the company provides commercial lending, consumer and other lending, asset-based lending, accounts receivable financing, equipment financing, vendor financing, Small Business Administration lending and servicing, treasury management services, and company retirement plans.
Pluristem Therapeutics is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company's product candidates include: PLX-PAD, which is in a multinational clinical trial in critical limb ischemia, and in a multinational clinical trial in recovery following surgery for hip fracture; PLX-R18, which is under development in the United States for acute radiation syndrome, as well as in a trial in the United States and Israel for incomplete hematopoietic recovery following hematopoietic cell transplantation; and PLX-Immune, which is under pre-clinical development for treatment of certain types of human cancer.
Simmons First National is a financial holding company. The company, through its subsidiaries, provides banking and other financial products and services in markets located in Arkansas, Colorado, Illinois, Kansas, Missouri, Oklahoma, Tennessee and Texas. The company's subsidiary, Simmons Bank, provides loans for corporate purposes, including financing commercial real estate, construction of particular properties, commercial and industrial uses, acquisition and equipment financings, and other general corporate needs. Simmons Bank also engages in small business administration and agricultural finance lending, and it provides corporate credit card products, as well as deposit and treasury management services.
Washington Federal is a bank holding company. Through its subsidiary, Washington Federal, National Association, the company's business consists of accepting deposits from the general public and investing these funds in loans of several types, including first lien mortgages on single-family dwellings, construction loans, land acquisition and development loans, loans on multi-family, commercial real estate and other income producing properties, home equity loans and business loans. The company invests in certain United States government and agency obligations and other investments permitted by applicable laws and regulations. Through its subsidiaries, the company is also engaged in insurance brokerage activities.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.